POSVAX R&D Center

• 

  Technology
  Using VLP System

  POSVAX is challenging the limit of the present drug technology using VLP system.

• 

  Discovering and Training
  Excellent Scientists

  The R&D center, authorized in June 2019, has provided opportunity to challenge new researches by discovering and training excellent scientists, and has sought technological innovation through enhancing biopharmaceuticals developing capability.

• 

  Global Bio-Pharmaceutical
  Company

  We, POSVAX, have the vision to become a global bio-pharmaceutical company by challenging vaccines and anticancer drugs industries.